Press Release: DeoBioScience : Oncology Biotech Startup, DeoBioSciences, Wraps Up First Public Investment Offering Campaign

ATLANTA, March 9, 2022 /PRNewswire/ -- In March 2022, DeoBioSciences, a cancer drug biotech start-up, is concluding its first equity crowdfunding offering to individual and institutional investors at Netcapital.com. The equity crowdfunding campaign, under the Regulation Crowdfunding (CF)...